Iron deficiency anemia in pregnancy. Iron deficiency anemia
Conditions
Interventions
Intervention 1: Intervention group 1: Anemic pregnant mothers who receive Ferrofort duodenal. In hemoglobin values 10-10.5, one capsule equivalent to 100 mg of Iron and for less values, 2 capsules equ
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: All pregnant women in 16-20 weeks of pregnancy
Exclusion criteria
Exclusion criteria: Intolerance or allergy to iron compounds Other anemia and hematological disorders except iron deficiency Blood transfusion 3 months before the treatment Chronic liver and kidney disease, asthma, epilepsy, HIV, coagulation disorders and thromboembolism Immunosuppressant drugs consumption Active and acute infection Alcohol and drug use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood hemoglobin. Timepoint: 2 months after the start of treatment. Method of measurement: Sampling from venous blood and complete blood count (CBC).;Serum Ferritin. Timepoint: 2 months after the start of treatment. Method of measurement: Sampling from venous blood and quantitatively measuring of Ferritin concentration of serum.;Digestive complications. Timepoint: 2 months after the start of treatment. Method of measurement: Interview.;Persistant consumption. Timepoint: 2 months after the start of treatment. Method of measurement: interview. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMamak Shariat
Tehran University of Medical Sciences
Outcome results
None listed